Overview
Miguel Weil practices in Tel Aviv, Israel. Mr. Weil is rated as an Elite expert by MediFind in the treatment of Hereditary Sensory and Autonomic Neuropathy Type 2. His top areas of expertise are Hereditary Sensory and Autonomic Neuropathy Type 2, Hajdu-Cheney Syndrome, Adult Polyglucosan Body Disease, and Familial Dysautonomia.
His clinical research consists of co-authoring 41 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 9 articles in the study of Hereditary Sensory and Autonomic Neuropathy Type 2.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Hajdu-Cheney SyndromeMr. Weil isElite. Learn about Hajdu-Cheney Syndrome.
- Hereditary Sensory and Autonomic Neuropathy Type 2
- Distinguished
- Adult Polyglucosan Body DiseaseMr. Weil isDistinguished. Learn about Adult Polyglucosan Body Disease.
- Advanced
- Familial DysautonomiaMr. Weil isAdvanced. Learn about Familial Dysautonomia.
- Experienced
- ABO IncompatibilityMr. Weil isExperienced. Learn about ABO Incompatibility.
- Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
- Dentatorubral-Pallidoluysian Atrophy
- Dihydrolipoamide Dehydrogenase Deficiency
- Embryonal Tumor with Multilayered Rosettes
- Glycogen Storage Disease Type 3Mr. Weil isExperienced. Learn about Glycogen Storage Disease Type 3.